Drug intelligence / Profile preview

Ferroguna

Development stage: Unknown
Lead developer: Guna
Modality: Small Molecules
Administration: Oral

Overview

Ferroguna is an oral dietary supplement developed by Guna S.p.a. designed to address iron deficiency and iron-deficiency anemia, particularly during pregnancy. It contains iron in the form of iron fumarate, which is supplemented with Vitamin C and Copper to optimize intestinal absorption and bioavailability. Additionally, it includes pulp from the fruit of the Baobab tree, which provides natural fiber and nutritional support. The supplement is formulated as orodispersible granules to improve patient compliance and gastrointestinal tolerability compared to traditional iron salts.

Brand names: Ferroguna

Beyond the preview

Go deeper on Ferroguna.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferroguna.

Explore the full profile